China
Guangdong · Shandong · Sichuan · Hubei · Jiangsu · Zhejiang · Hainan · Tibet · Henan · Hunan
WWHS Biotech Inc. ("WWHS") is a holding subsidiary of Sansure Biotech Inc. (stock code: 688289), co-founded by Professor Hongjie Dai, a world-renowned chemist, member of the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, and the American Academy of Arts and Sciences, and a Foreign Member of the Chinese Academy of Sciences. Built on second near-infrared window (NIR-II) fluorescence enhancement technology, the company is a National High-tech Enterprise and among the first to bring NIR-II fluorescence technology to in vitro diagnostics (IVD).
WWHS has developed nearly 100 NIR-II fluorescence point-of-care testing (POCT) products spanning inflammatory and infection markers, cardiac markers, tumor markers, and diabetes management. With superior anti-interference, ultra-high sensitivity, and outstanding stability, its platform breaks through the limitations of conventional POCT. Certified under NMPA and CE, WWHS serves numerous countries and regions worldwide, working to make NIR-II precision testing accessible to all.
Serving 20+ Countries and Regions Worldwide
Guangdong · Shandong · Sichuan · Hubei · Jiangsu · Zhejiang · Hainan · Tibet · Henan · Hunan
Mongolia · Indonesia · Vietnam · Malaysia · Philippines · Syria · Iraq · Israel
France
Egypt · Nigeria · Cameroon · Tanzania · Senegal · Burkina Faso · Togo · Benin · Uganda · Kenya
Guatemala
Fiji
Data updated as of: September 3, 2026
We use cookies to optimize your browsing experience. Click "Accept" to agree to our use of cookies.